Hemoglobin binding of bicyclic aromatic amines

Chemical Research in Toxicology

Volumn 11, Issue 5, 1998, Pages 471-483

  Sabbioni, Gabriele ^a   Schütze, Dietrich ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DICHLOROBENZIDINE; 3,4 METHYLENEDIOXYAMPHETAMINE; 4,4' METHYLENEBIS(2 CHLOROANILINE); AROMATIC AMIDE; BENZIDINE; DAPSONE; ELASTOMER; HEMOGLOBIN; MUTAGENIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; DNA SYNTHESIS; DRUG POTENCY; ELECTROCHEMISTRY; HEMOGLOBIN ANALYSIS; HYDROLYSIS; MUTAGENESIS; NONHUMAN; RAT;

AMINES; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DAPSONE; ELECTROCHEMISTRY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEMOGLOBINS; MUTAGENICITY TESTS; MUTAGENS; PROTEIN BINDING; RATS; RATS, WISTAR; SALMONELLA TYPHIMURIUM; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2642618626     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx9701642     Document Type: Article

References (51)

1. Ashby, J., Paton, D., Lefevre, P. A., Styles, J. A., and Rose, F. L. (1982) Evaluation of two suggested methods of deactivating organic carcinogens by molecular modification. Carcinogenesis 3, 1277-1282.
2. Holland, V. R., Saunders, B. C., Rose, F. L., and Walpole, A. L. (1974) Safer substitute for benzidine in the detection of blood. Tetrahedron 30, 3299-3302.
3. Shahin, M. M. (1989) The importance of analyzing structure-activity relationships in mutagenicity studies. Mutat. Res. 221, 165-180.
4. LaVoie, E., Tulley, L., Fow, E., and Hoffmann, D. (1979) Mutagenicity of aminobiphenyl and nitrophenyl ethers, sulfides, and disulfides. Mutat. Res. 67, 123-131.
5. Rao, T. K., Dorsey, G. F., Allen, B. E., and Epler, J. L. (1982) Mutagenicity of 4,4′-methylenedianiline derivatives in the Salmonella histidine reversion assay. Arch. Toxicol. 49, 185-190.
6. Messerly, E. A., Fekete, J. E., Wade, D. R., and Sinsheimer, J. E. (1987) Structure-mutagenicity relationships of benzidine analogues. Environ. Mol. Mutagen. 10, 263-274.
7. Debnath, A. K., Debnath, G., Shusterman, A. J., and Hansch, C. (1992) A QSAR investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 1. Mutagenicity of aromatic and heteroaromatic amines in Salmonella typhimuriun TA98 and TA100. Environ. Mol Mutagen. 19, 37-52.
8. McQueen, C. A., and Williams, G. M. (1990) Review of the genotoxicity and carcinogenicity of 4,4′-methylene-dianiline and 4,4′-methylene-bis-2-chloroaniline. Mutat. Res. 239, 133-142.
9. Gold, L. S., Manley, N. B., Slone, T. H., Garfinkel, G. B., Rohrbach, L., and Ames, B. N. (1993) The fifth plot of the carcinogeni potency database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. Environ. Health Perspect. 100, 65-135
10. Sabbioni, G., and Neumann, H.-G. (1990) Quantification of haemoglobin binding of 4,4′-methylenebis(2-chloroaniline) (MOCA) in rats. Arch. Toxicol. 64, 451-458.
11. Bailey, E., Brooks, A. G., Bird, I., Farmer, P. B., and Street, B. (1990) Monitoring exposure to methylenedianiline by the gas chromatography-mass spectrometry determination of adducts to hemoglobin. Anal. Biochem. 190, 175-181.
12. Cheever, K. L., Richards, D. E., Weigel, W. W., Begley, K. B. Savage, R. E., and Daniel, F. B. (1988) Macromolecular adduct formation by 4,4′-methylene-bis(2-chloroaniline) in adult male rat Scand. J. Work, Environ. Health 14 (Suppl. 1, Proc. Finn-U.S. Jt. Symp. Occup. Saf. Health Swed. Participation, 1988), 57-59
13. Cheever, K. L., Richards, D. E., Weigel, W. W., Begley, K. B., DeBord, D. G., Swearengin, T. F., and Savage, R. E., Jr. (1990) 4,4′-Methylene-bis(2-chloroaniline) (MOCA): comparison of macromolecular adduct formation after oral or dermal administration in the rat. Fundam. Appl. Toxicol. 14, 273-283.
14. Bailey, E., Brooks, A. G., Farmer, P. B., and Street, B. (1993) Monitoring exposure to methylene-bis(2-chloroaniline) through gas chromatography-mass spectrometry measurement of adducts to hemoglobin. Environ. Health Perspect. 190, 175-181.
15. Schütze, D., Sagelsdorff, P., Sepai, O., and Sabbioni, G. (1996) Synthesis and quantification of DNA adducts of 4,4′-methylene-dianiline. Chem Res. Toxicol. 9, 1103-1112.
16. Kugler-Steigmeier, M. E., Friederich, U., Graf, U., Lutz, W. K., Maier, P., and Schlatter, Ch. (1989) Genotoxicity of aniline derivatives in various short-term tests. Mutat. Res. 211, 279-289.
17. Ferstandig, L. L., and Scherrer, R. A. (1959) Mechanisms of isocyanate reactions with ethanol. J. Am. Chem. Soc. 81, 4838-4842.
18. Liefken, W. (1949) Mono- und Polyisocyanate. IV. Mitteilung über Polyurethane. Liebigs Ann. Chem. 526, 71-136.
19. Wingfoot Corp. U.S. Patent 2362648; Beilstein (III) 13, 461.
20. Wingfoot Corp. U.S. Patent 2362648; Beilstein (III) 13, 461.
21. Schütze, D., Sepai, O., Lewalter, J., Miksche, L., Henschler, D., and Sabbioni, G. (1995) Biomonitoring of workers exposed to 4,4′-methylenedianiline or 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 16, 573-582.
22. Collins, R. F., Davis, M., and Rosenbaum, J. (1969) Chemotherapy of Fascioliasis I. Derivatives of di-(p-aminophenyl)methane and p-aminophenol. J. Sci. Food Agric. 20, 690-695.
23. Ostromisslenski, I. (1908) Über die Einwirkung von Dichloressigsäure auf Anilin und seine Homologen. Ber. Deutsch. Chem. Ges. 41, 3019-3028.
24. Brode, W. R., and Piper, J. D. (1941) The relation between the absorption spectra and the chemical constitution of dyes. XVI. The separation of chromophores in unsymmetrical disazo dyes. J. Am. Chem. Soc. 63, 1502-1505.
25. Kaslow, C. E., and Stayner, R. D. (1946) Substituted 4-aminodiphenylmethanes. J. Am. Chem. Soc. 68, 2600-2602.
26. Universal Oil Prod. U.S. Patent 3189647; (1965) Chem. Abstr. 63, 8257f.
27. Universal Oil Prod. U.S. Patent 3189647; (1965) Chem. Abstr. 63, 8257f.
28. Sepai, O., Schütze, D., Heinrich, U., Hoymann, H. G., Henschler, D., and Sabbioni, G. (1995) Hemoglobin adducts and urine metabolites of 4,4′-methylenedianiline after 4,4′-methylenediphenyl diisocyanate exposure of rats. Chem.-Biol. Interact. 97, 185-198.
29. Hesse, M., Meier, H., and Zeeh, B. (1984) Spektroskopische Methoden in der organischen Chemie, Georg Thieme Verlag, Stuttgart.
30. Breitmeier, E., and Voelter, W. (1987) Carbon-NMR Spectroscopy, VCH Verlagsgesellschaft, Weinheim, Germany.
31. Suzuki, J., Meguro, S.-I., Morita, O., Hyrajama, S., and Suzuki, S. (1989) Comparison of in vivo binding of aromatic nitro and amino compounds to rat hemoglobin. Biochem. Pharmacol. 38, 3511-3519.
32. Shintani, H. (1992) Solid-phase extraction and HPLC analysis of toxic compounds and comparison of SPE and liquid - liquid extraction. I. Analysis of 4,4′-methylenedianiline in serum. II. Analysis of the components of dental materials. J. Liquid Chromatogr. 15, 1315-1318.
33. Sabbioni, G. (1992) Quantitative structure activity relationship of the N-oxidation of aromatic amines. Chem.-Biol. Interact. 81, 91-117.
34. Andres, H. H., Vogel, R. S., Tarr, G. E., Johnson, L., and Weber, W. W. (1987) Purification, physicochemical and kinetic properties of liver acetyl-CoA: Arylamine N - Acetyltransferase from rapid acetylator rabbits. Mol. Pharmacol. 31, 446-456.
35. Risch, A., Smelt, V., Lane, D., Stanley, L., van der Slot, W., Ward, A., and Sim, E. (1996) Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients. Pharmacol. Toxicol. 78, 235-240.
36. Ducos, P., Maire, C., and Gaudin, R. (1985) Assessment of occupational exposure to 4,4′-methylene-bis-(2-chloroaniline) "MOCA" by a new sensitive method for biological monitoring. Int. Arch. Occup. Environ. Health 55, 159-167.
37. Cocker, J., Boobis, A. R., and Davies, D. S. (1986) Routes of activation of 4,4′-methylenebis-(2-chloroaniline) and 4,4′-methylenedianiline to bacterial mutagens. Food Chem. Toxicol. 24, 755-756.
38. Cocker, J., Boobis, A. R., and Davies, D. S. (1988) Determination of the N-acetyl metabolites of 4,4′-methylenedianiline and 4,4′-methylene-bis(2-chloroaniline) in urine. Biomed. Environ. Mass Spectrom. 17, 161-167.
39. Cocker, J., Nutley, B. P., and Wilson, H. K. (1996) Methylene bis-(2-chloroaniline (MbOCA): towards a biological monitoring guidance value. Biomarkers 1, 185-189.
40. Kadlubar, F. F., and Hammons, G. J. (1987) Mammalian Cytochromes P 450, Vol. II, Chapter 3, pp 81-130, CRC Press, Boca Raton, FL.
41. Yun, C.-H., Shimada, T., and Guengerich, F. P. (1992) Contributions of human liver cytochrome P450 enzymes to the N-oxidation of 4,4′-methylene-bis(2-chloroaniline). Carcinogenesis 13, 217-222.
42. Frederick, C. B., Weis, C. C., Flammang, T. J., Martin, C. N., and Kadlubar, F. F. (1985) Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine. Carcinogenesis 6, 959-965.
43. Kenelly, J. C., Beland, F. A., Kadlubar, F. F., and Martin, C. N. (1984) Binding of N-acetylbenzidine and N,N′-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro. Carcinogenesis 5, 407-412.
44. Birner, G., Albrecht, W., and Neumann, H.-G. (1990) Biomonitoring of aromatic amines III. Hemoglobin binding of benzidine and some benzidine congeners. Arch. Toxicol. 64, 97-102.
45. Beilis, Y. I. (1970) Investigation of aromatic amines by the method of oxidative polarography. II. J. Gen. Chem. U.S.S.R. 40, 721-725.
46. Sabbioni, G. (1994) Hemoglobin binding of arylamines and nitroarenes: molecular dosimetry and quantitative structure activity relationships. Environ. Health Perspect. 102 (Suppl. 6), 61-67.
47. Sabbioni, G., and Sepai, O. (1995) Comparison of hemoglobin binding, mutagenicity and carcinogenicity of arylamines and nitroarenes. Chimia 49, 374-380.
48. Tanaka, K., Mii, T., Marui, S., Matsubara, I., and Igaki, H. (1981) Mutagenicity of urinary metabolites of benzidine and benzidine-based azo dyes. Int. Arch. Occup. Environ. Health 49, 177-185.
49. Wu, K., Bonin, A. M., Leslie, C. L., Baker, R. S. U., and Stacey, N. H. (1989) Genotoxicity and effects on rat liver drug-metabolizing enzymes by possible substitutes for 4,4′-methylene bis(2-chloroaniline). Carcinogenesis 10, 2119-2122.
50. Birner, G., and Neumann, H.-G. (1988) Biomonitoring of aromatic amines. II: Hemoglobin binding of some monocyclic aromatic amines. Arch. Toxicol. 62, 110-115.
51. Peters, J. H., Gordon, G. R., Murray, J. F., Jr., and Simmon, V. F. (1983) Mutagenic activity of antileprosy drugs and their derivatives. Int. J. Lepr. Other Mycobact. Dis. 51, 45-53.